AI
AMED

Atria Investments’s Amedisys AMED Stock Holding History

Atria Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,190
Closed -$201K – 1901
2024
Q2 		$201K Buy
+2,190
New +$203K ﹤0.01% 1820
2021
Q3 		– Sell
-4,167
Closed -$1.02M – 785
2021
Q2 		$1.02M Sell
4,167
-390
-9% -$102K 0.02% 749
2021
Q1 		$1.21M Buy
4,557
+692
+18% +$195K 0.03% 636
2020
Q4 		$1.13M Buy
+3,865
New +$991K 0.03% 631
2020
Q2 		– Sell
-2,945
Closed -$541K – 522
2020
Q1 		$541K Sell
2,945
-339
-10% -$60.3K 0.04% 335
2019
Q4 		$548K Buy
+3,284
New +$488K 0.01% 749
2018
Q3 		– Sell
-2,730
Closed -$233K – 972
2018
Q2 		$233K Buy
+2,730
New +$200K 0.01% 836

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atria Investments's AMED Position: Q3 2024 in Review

Atria Investments sold out of Amedisys (AMED) in Q3 2024, closing a stake of 2,190 shares — an estimated $201K sold.

Atria Investments first reported a position in AMED in Q2 2018 and held it in 7 quarters. The position peaked at $1.21M in Q1 2021. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Atria Investments reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Atria Investments sold 2,190 Amedisys shares in Q3 2024, an estimated $201K.
  • Atria Investments first reported a position in Amedisys in Q2 2018 and held it in 7 quarters.
  • Atria Investments's Amedisys position peaked at $1.21M in Q1 2021.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Atria Investments's 13F filing for Q3 2024, filed 1 Nov 2024.